Dris, Mosmera .

HRN: 14-82-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
CEFUROXIME 1.5GM (VIAL)
07/16/2025
07/18/2025
IV
1.5 G
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: